| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 32.027 | - | 38.122 | 52.657 | 63.203 | 61.035 | 57.573 | 86.386 | 101.158 |
| Total Income - EUR | - | 32.027 | - | 38.122 | 52.657 | 63.203 | 61.035 | 57.573 | 86.387 | 102.225 |
| Total Expenses - EUR | - | 18.479 | - | 27.041 | 22.555 | 28.530 | 27.013 | 22.605 | 54.850 | 46.532 |
| Gross Profit/Loss - EUR | - | 13.548 | - | 11.081 | 30.102 | 34.672 | 34.022 | 34.968 | 31.537 | 55.693 |
| Net Profit/Loss - EUR | - | 13.116 | - | 10.699 | 29.576 | 34.040 | 33.456 | 34.392 | 30.687 | 52.933 |
| Employees | - | 0 | - | 3 | 0 | 4 | 0 | 0 | 3 | 3 |
Check the financial reports for the company - Magda Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 7.154 | - | 6.904 | 6.770 | 6.642 | 6.065 | 6.083 | 6.065 | 29.895 |
| Current Assets | - | 46.534 | - | 23.909 | 30.565 | 36.717 | 43.155 | 92.163 | 47.783 | 54.759 |
| Inventories | - | 334 | - | 0 | 201 | 0 | 157 | 172 | 0 | 23.119 |
| Receivables | - | 449 | - | 10.229 | 0 | 0 | 4.449 | 5.769 | 10.535 | 5.917 |
| Cash | - | 45.751 | - | 13.680 | 30.365 | 36.717 | 38.550 | 86.222 | 37.248 | 25.723 |
| Shareholders Funds | - | 52.990 | - | 17.647 | 36.809 | 34.082 | 38.179 | 95.413 | 51.528 | 76.858 |
| Social Capital | - | 0 | - | 43 | 42 | 41 | 0 | 0 | 40 | 40 |
| Debts | - | 698 | - | 13.167 | 526 | 9.278 | 11.041 | 2.833 | 2.321 | 7.796 |
| Income in Advance | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Magda Med Srl